ICON has established a Cardiac Scientific Advisory Board comprised of experts across several cardiology disciplines, which will advise ICON’s Medical Imaging division on strategic initiatives, including the role of cardiac imaging in clinical trials, and the safety and adjudication of clinical events.
The board is comprised of the following members:
- Nelson B. Schiller, MD, professor of medicine, radiology and anesthesiology at the University of California, San Francisco. He is director of echocardiography research at the Veterans Administration Hospital in San Francisco.
- C. Michael Gibson MS, MD, an interventional cardiologist and chief of clinical research in the division of cardiology at Harvard’s Beth Israel Deaconess Medical Center in Boston. Gibson’s work has largely focused on the pathophysiology of acute coronary syndromes and the efficacy of pharmacologic and device-based therapies for coronary artery disease.
- Harald Becher, MD, PhD, a consultant cardiologist at the John Radcliffe Hospital in Oxford, England, where he also directs the echocardiography laboratory. He is a professor of cardiac ultrasound at Oxford University.
- Scott D. Solomon, MD, an associate professor of medicine at Harvard Medical School, and director of noninvasive cardiology at Brigham and Women’s Hospital; both in Boston. Solomon is the director of the Echocardiography Core Laboratory at Brigham’s, where he also co-directs the Clinical Trials Endpoints Center.
The group will be coordinated by Jonathan Goldman, MD, chief medical officer at ICON Medical Imaging of Warrington, Pa. Goldman is an academic imaging cardiologist with the University of California, San Francisco.